StockData
LMRINasdaqServices-Medical LaboratoriesFiscal year ends December 31

Lumexa Imaging Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$10.72−0.06 (-0.56%)

Close on Oct 19, 2026

Market cap
$1.03B
P/E (TTM)
–
Dividend yield
–

SEC filings

14 of Lumexa Imaging's most recent filings on SEC EDGAR

DocumentFormPeriodFiledSource
Quarterly report10-QJun 30, 2026Aug 13, 2026SEC EDGAR
Current report8-KAug 12, 2026Aug 12, 2026SEC EDGAR
Current report8-KJun 30, 2026Jun 30, 2026SEC EDGAR
Current report8-KJun 10, 2026Jun 12, 2026SEC EDGAR
Quarterly report10-QMar 31, 2026May 12, 2026SEC EDGAR
Current report8-KMay 12, 2026May 12, 2026SEC EDGAR
Proxy statementDEF 14AJun 10, 2026Apr 28, 2026SEC EDGAR
Current report8-KApr 8, 2026Apr 9, 2026SEC EDGAR
Annual report10-KDec 31, 2025Mar 30, 2026SEC EDGAR
Current report8-KMar 26, 2026Mar 26, 2026SEC EDGAR
Current report8-KMar 2, 2026Mar 2, 2026SEC EDGAR
Current report8-KJan 12, 2026Jan 15, 2026SEC EDGAR
Current report8-KDec 17, 2025Dec 18, 2025SEC EDGAR
Current report8-KDec 12, 2025Dec 12, 2025SEC EDGAR